Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 1 |
1
Johnson & Johnson
JNJ
$623B
| 4,199 | +105 | +3% | $321B |
|
| 2 |
2
Abbott
ABT
$181B
| 3,184 | -8 | -0.3% | $182B |
|
| 3 |
3
Stryker
SYK
$111B
| 2,275 | +17 | +0.8% | $110B |
|
| 4 |
4
Medtronic
MDT
$122B
| 2,178 | +32 | +1% | $102B |
|
| 5 |
5
Danaher
DHR
$161B
| 2,150 | -26 | -1% | $111B |
|
| 6 |
6
Intuitive Surgical
ISRG
$150B
| 2,117 | -153 | -7% | $130B |
|
| 7 |
7
Boston Scientific
BSX
$63.7B
| 1,716 | +22 | +1% | $131B |
|
| 8 |
8
Becton Dickinson
BDX
$52.5B
| 1,485 | -35 | -2% | $48.3B |
|
| 9 |
9
DuPont de Nemours
DD
$17.6B
| 1,361 | +30 | +2% | $23.9B |
|
| 10 |
10
Roper Technologies
ROP
$38.1B
| 1,290 | -57 | -4% | $48.5B |
|
| 11 |
11
GE HealthCare
GEHC
$32B
| 1,282 | -35 | -3% | $28.4B |
|
| 12 |
12
Edwards Lifesciences
EW
$49.6B
| 1,255 | -6 | -0.5% | $38.2B |
|
| 13 |
13
Agilent Technologies
A
$49.3B
| 1,043 | +33 | +3% | $32.2B |
|
| 14 |
14
Labcorp
LH
$26.1B
| 1,013 | +37 | +4% | $22.2B |
|
| 15 |
15
Quest Diagnostics
DGX
$26.1B
| 1,007 | +15 | +2% | $20B |
|
| 16 |
16
Zimmer Biomet
ZBH
$18B
| 971 | +32 | +3% | $18.9B |
|
| 17 |
17
ResMed
RMD
$33.8B
| 950 | +30 | +3% | $25.1B |
|
| 18 |
18
DexCom
DXCM
$32.5B
| 911 | -28 | -3% | $24.5B |
|
| 19 |
19
Solventum
SOLV
$15B
| 872 | -20 | -2% | $8.9B |
|
| 20 |
20
Steris
STE
$21.7B
| 844 | +8 | +1% | $22.7B |
|
| 21 |
21
Insulet
PODD
$9.51B
| 814 | +17 | +2% | $21.1B |
|
| 22 |
22
Waters Corp
WAT
$43.3B
| 756 | -14 | -2% | $17.2B |
|
| 23 |
23
DELISTED
Hologic
HOLX
| 740 | +46 | +7% | $14.4B |
|
| 24 |
24
Baxter International
BAX
$13.3B
| 734 | -42 | -5% | $11.5B |
|
| 25 |
25
Natera
NTRA
$57.8B
| 686 | +39 | +6% | $20.8B |
|